Related Experiment Video
Updated: Jul 14, 2026
06:46
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Hyperglycemia and externalizing behavior in children with type 1 diabetes
Ciara M McDonnell1, Elisabeth A Northam, Susan M Donath
1Department of Endocrinology and Diabetes, Royal Children's Hospital, University of Melbourne, Parkville, Melbourne, Victoria, Australia.
Diabetes Care
|June 15, 2007
Summary
Behavioral changes in children with type 1 diabetes are linked to blood glucose fluctuations. Specifically, externalizing behaviors increased with higher glucose levels and decreased with more time in the normal range.
Area of Science:
- Pediatric Endocrinology
- Child Psychology
- Diabetes Management
Background:
- Parental reports suggest behavioral changes in diabetic children correlating with blood glucose variability.
- Understanding these associations is crucial for comprehensive diabetes care.
Purpose of the Study:
- To investigate the relationship between glycemic status and child behavior in children with type 1 diabetes.
- To quantify associations between intercurrent glycemia and behavioral assessments.
Main Methods:
- Prepubertal children with type 1 diabetes underwent continuous glucose monitoring over 72 hours.
- Parental behavioral assessments using the Behavior Assessment System for Children were conducted at two 6-month intervals.
Main Results:
- Externalizing behaviors showed a significant association with mean blood glucose and time spent in normal or high glycemic ranges.
- Increased time in normal glycemic range correlated with decreased externalizing behaviors, while increased time in high range correlated with increased externalizing behaviors.
- No significant association was found between glycemic status and internalizing behaviors.
Conclusions:
- Externalizing behaviors in children with type 1 diabetes are significantly associated with their glycemic status.
- Further research into the mechanisms underlying this association is warranted to improve diabetes outcomes.
Related Concept Videos
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...